DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Rodrigo SF, van Ramshorst J, Hoogslag GE, Boden H, Velders MA, Cannegieter SC, Roelofs H, Al Younis I, Dibbets-Schneider P, Fibbe WE, Zwaginga JJ, Bax JJ, Schalij MJ, Beeres SL, Atsma DE.
Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up.
J Cardiovasc Transl Res 2013;
6: 816-825
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.